Current price is more than the intrinsic value

Intrinsic value

Stock has not been able to generate better return on equity than bank FD

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1175 in its research report dated February 01, 2023.

Buy Sun Pharmaceutical Industries; target of Rs 1175: Prabhudas Lilladher

ICICI Direct is bullish on Sun Pharmaceutical Industries recommended buy rating on the stock with a target price of Rs 1210 in its research report dated February 01, 2023.

Buy Sun Pharmaceutical Industries; target of Rs 1210: ICICI Direct

HUL, Sun Pharma, Tech Mahindra, Eicher Motors and UPL were among the biggest Nifty gainers. The losers included UltraTech Cement, Grasim Industries, NTPC, JSW Steel and Tata Steel

Taking Stock | Market snaps 2-day losing streak, Sensex gains 319 points, Nifty above 18,100

Stocks to watch out for today: Adani Enterprises, Sun Pharma, Indian Oil, UPL, Lupin, Reliance Industries, Max Financial , Jindal Steel and more

Stocks in news: Adani Enterprises, Reliance Industries, Jindal Steel, Lupin and more

ICICI Bank, Tata Steel, HDFC, HDFC Bank, Kotak Mahindra Bank were the major gainers and jumped as much as 2.92%. On the other hand, ITC, Mahindra & Mahindra, Sun Pharma were the laggards.

Union Budget 2023 | Sensex jumps 640 points; Nifty nears 17,800 level

The company’s third-quarter net profit rose 5% year-on-year to Rs 2,166 crore.

Sun Pharma Q3 Review: Analysts Optimistic On Global Specialty Pipeline, India Business

Performance was inline, despite regulatory hurdle at Halol, step-up in other expenses, due to higher selling, distribution spent.

Sun Pharma Q3 Results Review - Specialty Sales Remains Encouraging: Motilal Oswal

The recent acquisition of Concert Pharmaceutical reiterates management’s increased focus on its specialty business.

Sun Pharma Q3 Results Review - Inline Performance; Valuations Fair: ICICI Securities

Despite higher specialty sales, gross margins were flattish impacted by inventory provision of Halol plant.

Sun Pharma Q3 Results Review - Performance Largely Inline: Dolat Capital

Earnings before interest, depreciation, tax, and amortisation (EBITDA) came in at Rs 3,004 crore, 15 percent higher from Rs 2,606 crore reported last year. EBITDA margin widened by 30 bps to 26.7 percent on a yearly basis as against 26.4 percent a year ago.

Sun Pharma Q3 profit rises to Rs 2,166 crore; brokerages suggest ‘buy’ with 16% upside

Despite the impact of Halol import alert, the U.S. business grew 5% QoQ led by growth in specialty assets.

Sun Pharma Q3 Results Review - Inline Performance; Growth Levers In Place: Systematix

Sun Pharmaceutical Industries Limited is a pharmaceuticals company which offers generics, branded generics, specialty products, over-the-counter products, anti-retroviral and APIs.

Sun Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Ltd

Intrinsic value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Buy Sun Pharmaceutical Industries; target of Rs 1175: Prabhudas Lilladher

Buy Sun Pharmaceutical Industries; target of Rs 1210: ICICI Direct

Taking Stock | Market snaps 2-day losing streak, Sensex gains 319 points, Nifty above 18,100

Stocks in news: Adani Enterprises, Reliance Industries, Jindal Steel, Lupin and more

Union Budget 2023 | Sensex jumps 640 points; Nifty nears 17,800 level

Sun Pharma Q3 Review: Analysts Optimistic On Global Specialty Pipeline, India Business

Sun Pharma Q3 Results Review - Specialty Sales Remains Encouraging: Motilal Oswal

Sun Pharma Q3 Results Review - Inline Performance; Valuations Fair: ICICI Securities

Sun Pharma Q3 Results Review - Performance Largely Inline: Dolat Capital

Sun Pharma Q3 profit rises to Rs 2,166 crore; brokerages suggest ‘buy’ with 16% upside

Sun Pharmaceutical Industries Ltd

Intrinsic valueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry pointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Buy Sun Pharmaceutical Industries; target of Rs 1175: Prabhudas Lilladher

Buy Sun Pharmaceutical Industries; target of Rs 1210: ICICI Direct

Taking Stock | Market snaps 2-day losing streak, Sensex gains 319 points, Nifty above 18,100

Stocks in news: Adani Enterprises, Reliance Industries, Jindal Steel, Lupin and more

Union Budget 2023 | Sensex jumps 640 points; Nifty nears 17,800 level

Sun Pharma Q3 Review: Analysts Optimistic On Global Specialty Pipeline, India Business

Sun Pharma Q3 Results Review - Specialty Sales Remains Encouraging: Motilal Oswal

Sun Pharma Q3 Results Review - Inline Performance; Valuations Fair: ICICI Securities

Sun Pharma Q3 Results Review - Performance Largely Inline: Dolat Capital

Sun Pharma Q3 profit rises to Rs 2,166 crore; brokerages suggest ‘buy’ with 16% upside

Intrinsic value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock